\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ physical\\ examination\ \(1\)\
\-\ normal\\ laboratory\\ studies\\ including\\ csf\\ analysis\ \(0\)\
\-\ mri\\ in\\ june\\,\\ 2009\\ revealed\\ lesion\\ in\\ right\\ cerebellar\\ hemisphere\\.\\ repeat\\ mri\\ in\\ october\\ revealed\\ complete\\ resolution\\ of\\ lesion\\.\ \(0\)\
\-\ no\\ specific\\ treatment\\ given\ \(0\)\
\-\ focal\\ region\\ of\\ elevated\\ signal\\ intensity\\ right\\ cerebellar\\ hemisphere\\.\ \(0\)\
\-\ no\\ associated\\ mass\\ effect\\ or\\ contrast\\ enhancement\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ astrocytoma\ \(206\)\
\-\ hamartoma\ \(55\)\
\-\ infarction\ \(233\)\
\-\ 8\\ year\\ old\\ boy\\ with\\ first\\ time\\ seizure\\.\ \(1\)\
\-\ it\\ is\\ unusual\\ for\\ cerebellar\\ lesions\\ to\\ cause\\ seizures\\.\\ \\ there\\ may\\ be\\ a\\ supratentorial\\ process\\ that\\ is\\ not\\ shown\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cerebellar\\:\\ 0\\.37188832895567586\ \(0\)\
\-\ hemisphere\\:\\ 0\\.2835174709292778\ \(0\)\
\-\ revealed\\:\\ 0\\.1986475714051457\ \(0\)\
\-\ october\\:\\ 0\\.1870281237129477\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.177391210337848\ \(0\)\
\-\ june\\:\\ 0\\.17413551986709086\ \(0\)\
\-\ supratentorial\\:\\ 0\\.17216759124526346\ \(0\)\
\-\ disseminated\\:\\ 0\\.16405821689231187\ \(0\)\
\-\ 2009\\:\\ 0\\.1633684408577871\ \(0\)\
\-\ mri\\:\\ 0\\.15551147007668578\ \(0\)\
\-\ hamartoma\\:\\ 0\\.14899877050397756\ \(0\)\
\-\ lesion\\:\\ 0\\.14524453792078404\ \(0\)\
\-\ analysis\\:\\ 0\\.1408685442581286\ \(0\)\
\-\ unusual\\:\\ 0\\.1358331842905147\ \(0\)\
\-\ repeat\\:\\ 0\\.13286689777803512\ \(0\)\
\-\ seizure\\:\\ 0\\.12604973196279706\ \(0\)\
\-\ normal\\:\\ 0\\.12369549279108234\ \(0\)\
\-\ seizures\\:\\ 0\\.12365578001797506\ \(0\)\
\-\ resolution\\:\\ 0\\.12290346669404582\ \(0\)\
\-\ csf\\:\\ 0\\.1196934620569064\ \(0\)\
\-\ infarction\\:\\ 0\\.11891619044325678\ \(0\)\
\-\ shown\\:\\ 0\\.11742674114923667\ \(0\)\
\-\ specific\\:\\ 0\\.11478628552515084\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.11435272676389899\ \(0\)\
\-\ process\\:\\ 0\\.11361062581738945\ \(0\)\
\-\ in\\:\\ 0\\.11304896961171983\ \(0\)\
\-\ studies\\:\\ 0\\.11111771927903079\ \(0\)\
\-\ laboratory\\:\\ 0\\.10999945366036998\ \(0\)\
\-\ including\\:\\ 0\\.10840568235975453\ \(0\)\
\-\ intensity\\:\\ 0\\.10755991392024808\ \(0\)\
\-\ effect\\:\\ 0\\.1062603330472973\ \(0\)\
\-\ complete\\:\\ 0\\.1061811828121256\ \(0\)\
\-\ given\\:\\ 0\\.10420196624783688\ \(0\)\
\-\ boy\\:\\ 0\\.10362150850851282\ \(0\)\
\-\ elevated\\:\\ 0\\.10326506175743727\ \(0\)\
\-\ cause\\:\\ 0\\.10319434298264447\ \(0\)\
\-\ first\\:\\ 0\\.10222356025982883\ \(0\)\
\-\ right\\:\\ 0\\.10044292765656933\ \(0\)\
\-\ no\\:\\ 0\\.09851831337435092\ \(0\)\
\-\ examination\\:\\ 0\\.09693193886570234\ \(0\)\
\-\ focal\\:\\ 0\\.09060772472755928\ \(0\)\
\-\ region\\:\\ 0\\.09060772472755928\ \(0\)\
\-\ time\\:\\ 0\\.08978525833266322\ \(0\)\
\-\ enhancement\\:\\ 0\\.08718851532898028\ \(0\)\
\-\ lesions\\:\\ 0\\.08699594824696773\ \(0\)\
\-\ signal\\:\\ 0\\.08586898064784196\ \(0\)\
\-\ is\\:\\ 0\\.08296695421282765\ \(0\)\
\-\ physical\\:\\ 0\\.08213524028510359\ \(0\)\
\-\ acute\\:\\ 0\\.081944197128449\ \(0\)\
\-\ associated\\:\\ 0\\.07984064571825551\ \(0\)\
\-\ it\\:\\ 0\\.07753984048134292\ \(0\)\
\-\ may\\:\\ 0\\.07622886923766396\ \(0\)\
\-\ contrast\\:\\ 0\\.07360041810587896\ \(0\)\
\-\ treatment\\:\\ 0\\.07215735290092787\ \(0\)\
\-\ that\\:\\ 0\\.06573608456376573\ \(0\)\
\-\ be\\:\\ 0\\.06144886163572143\ \(0\)\
\-\ there\\:\\ 0\\.060272913285717794\ \(0\)\
\-\ not\\:\\ 0\\.05980019605703569\ \(0\)\
\-\ of\\:\\ 0\\.059287430750448046\ \(0\)\
\-\ mass\\:\\ 0\\.057860827960258925\ \(0\)\
\-\ or\\:\\ 0\\.05269675001873809\ \(0\)\
\-\ year\\:\\ 0\\.04668275969078116\ \(0\)\
\-\ for\\:\\ 0\\.04591203802021586\ \(0\)\
\-\ old\\:\\ 0\\.04483160894144375\ \(0\)\
\-\ to\\:\\ 0\\.03786938289475106\ \(0\)\
\-\ with\\:\\ 0\\.02966142748809701\ \(0\)\
